Skip to content
DataLookout
Menu

NCT07885423

68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 1 with changes below, 2 re-verified with no change.

  1. Study First Submitted

Endpoints

Primary

Diagnostic efficacy
Timeframe: 1 month

Secondary (2)

Concordance Between Intraoperative Fluorescence Imaging and Histopathology for Prostate Surgical Margin Assessment
Concordance Between Intraoperative Fluorescence Imaging and Histopathology for Pelvic Lymph Node Assessment

Arms and interventions

68Ga-XMFH01Experimental

Participants will undergo preoperative 68Ga-XMFH01 PET/CT imaging for tumor detection and localization, followed by intraoperative fluorescence-guided surgical navigation using the same dual-modality probe.

Diagnostic tests: 68Ga-XMFH01 PET/CT

Sites

1 site in 1 country

  • The First Affiliated Hospital of Xiamen UniversityXiamen, Fujian, China